Verge Genomics Reports Digital Biomarkers May Track Early ALS Progression in Pre-Treatment Trial Phase

New findings from Verge Genomics suggest that digital clinical biomarkers can detect short-term ALS progression even before treatment begins, offering …

Continue ›››

Aelius Biotech Raises £750K to Expand In Vitro Gut Model Platform for Drug and Food R&D

Aelius Biotech, a Newcastle-based biotech company developing a non-animal laboratory gut model, has secured an additional £750,000 from the North …

Continue ›››

Pharma Supply: SkyCell Partners with Microsoft to Launch AI Co-Pilot for Shipment Monitoring

SkyCell, a Swiss company specializing in pharmaceutical logistics, has launched K.AI—an AI-powered chatbot developed in collaboration with Microsoft—to enhance visibility, …

Continue ›››

$1B AI Drug Discovery Startup Xaira Therapeutics Appoints Foundation Model Expert Bo Wang as Head of Biomedical AI

Xaira Therapeutics, an AI-driven biotech launched in April 2024 with over $1 billion in funding, has appointed Dr. Bo Wang …

Continue ›››

Paige’s AI Tool for Multi-Tissue Cancer Detection Gets FDA's Breakthrough Device Designation

Paige has received Breakthrough Device designation from the U.S. FDA for PanCancer Detect, an AI-based diagnostic tool intended to assist …

Continue ›››

Differential Bio Emerges from Stealth with €2M to Scale AI-Driven Biomanufacturing

Differential Bio, a Munich-based startup focused on AI-powered biomanufacturing, has emerged from stealth with €2 million in pre-seed funding.  The …

Continue ›››

Medtronic Partners with Methinks AI to Expand AI-Driven Stroke Assessment in EMEA

Medtronic, one of the world’s largest medical device companies by revenue, has announced a strategic partnership with Methinks AI to …

Continue ›››

Siemens to Acquire Dotmatics for $5.1B

Siemens has announced a $5.1 billion acquisition of Dotmatics from Insight Partners, with closing expected in the first half of …

Continue ›››

Aqemia Secures $7.4M to Expand RNA-Targeting Programs With Physics-Based Generative AI

Aqemia has announced a $7.4 million grant from the France 2030 investment plan to accelerate its work in RNA-targeted drug …

Continue ›››

Isomorphic Labs Raises $600M to Advance AI Drug Design and Internal Pipeline

Isomorphic Labs has secured $600 million in its first external funding round to accelerate the development of its AI-based drug …

Continue ›››

Turn Bio Acquires Vesigen’s Microvesicle Delivery System for Epigenetic Therapies

Turn Biotechnologies, a biotechnology company based in Mountain View, California, announced on March 26, 2025, the acquisition of ARMMs (ARRDC1-Mediated …

Continue ›››

seca Presents Real-Time Body Composition Tracker for GLP-1 Patients

seca, a global Hamburg-based medical measurement company founded in 1840, has introduced a new software platform called "Treatment Tracker," which …

Continue ›››